Article Text
Letters
Dominant Epstein–Barr virus-specific T-cell responses are maintained during moderate and intense immunosuppressive treatment
Statistics from Altmetric.com
Footnotes
-
Funding TD is supported by the FAG (‘Freiwillige Akademische Gesellschaft’) of Basel and by an EULAR bursary, CH by the Swiss National Science Foundation (SNSF) (PP00B-114850).
-
Competing interests None.
-
Patient consent Obtained.
-
Ethics approval This study was conducted with the approval of the Ethik Komission beider Basel.
-
Provenance and peer review Not commissioned; externally peer reviewed.